MEDirect Latino, Inc.
MEDirect Latino, Inc. (MLTO) Stock Competitors & Peer Comparison
See (MLTO) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MLTO | $0.00 | N/A | 1.7K | -0.00 | -$0.50 | N/A |
| SHPMF | $1.46 | +0.00% | 8.5B | 6.64 | $0.22 | +3.81% |
| SHTDF | $2.68 | +0.00% | 8.4B | 8.65 | $0.31 | +3.51% |
| SHTDY | $13.04 | +0.49% | 8B | 7.77 | $1.66 | +2.75% |
| GALNF | $116.19 | +0.00% | 5.8B | 24.99 | $4.65 | +2.47% |
| SHPMY | $7.60 | +0.00% | 5.6B | 6.85 | $1.11 | +3.44% |
| CAKFY | $4.10 | +0.00% | 5.4B | -68.33 | -$0.06 | N/A |
| MEPDF | $19.00 | +0.00% | 3.9B | 15.45 | $1.23 | +2.19% |
| MAHLY | $17.68 | +0.00% | 3.6B | 14.37 | $1.23 | +1.85% |
| ALFRY | $16.81 | +3.61% | 2.9B | 19.09 | $0.85 | +1.41% |
Stock Comparison
MLTO vs SHPMF Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, SHPMF has a market cap of 8.5B. Regarding current trading prices, MLTO is priced at $0.00, while SHPMF trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas SHPMF's P/E ratio is 6.64. In terms of profitability, MLTO's ROE is N/A, compared to SHPMF's ROE of +0.08%. Regarding short-term risk, MLTO is more volatile compared to SHPMF. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check SHPMF's competition here
MLTO vs SHTDF Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, SHTDF has a market cap of 8.4B. Regarding current trading prices, MLTO is priced at $0.00, while SHTDF trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas SHTDF's P/E ratio is 8.65. In terms of profitability, MLTO's ROE is N/A, compared to SHTDF's ROE of +0.09%. Regarding short-term risk, MLTO is more volatile compared to SHTDF. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check SHTDF's competition here
MLTO vs SHTDY Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, SHTDY has a market cap of 8B. Regarding current trading prices, MLTO is priced at $0.00, while SHTDY trades at $13.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas SHTDY's P/E ratio is 7.77. In terms of profitability, MLTO's ROE is N/A, compared to SHTDY's ROE of +0.09%. Regarding short-term risk, MLTO is more volatile compared to SHTDY. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check SHTDY's competition here
MLTO vs GALNF Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, GALNF has a market cap of 5.8B. Regarding current trading prices, MLTO is priced at $0.00, while GALNF trades at $116.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas GALNF's P/E ratio is 24.99. In terms of profitability, MLTO's ROE is N/A, compared to GALNF's ROE of +0.12%. Regarding short-term risk, MLTO is more volatile compared to GALNF. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check GALNF's competition here
MLTO vs SHPMY Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, SHPMY has a market cap of 5.6B. Regarding current trading prices, MLTO is priced at $0.00, while SHPMY trades at $7.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas SHPMY's P/E ratio is 6.85. In terms of profitability, MLTO's ROE is N/A, compared to SHPMY's ROE of +0.08%. Regarding short-term risk, MLTO is more volatile compared to SHPMY. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check SHPMY's competition here
MLTO vs CAKFY Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, CAKFY has a market cap of 5.4B. Regarding current trading prices, MLTO is priced at $0.00, while CAKFY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas CAKFY's P/E ratio is -68.33. In terms of profitability, MLTO's ROE is N/A, compared to CAKFY's ROE of -0.02%. Regarding short-term risk, MLTO is more volatile compared to CAKFY. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check CAKFY's competition here
MLTO vs MEPDF Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, MEPDF has a market cap of 3.9B. Regarding current trading prices, MLTO is priced at $0.00, while MEPDF trades at $19.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas MEPDF's P/E ratio is 15.45. In terms of profitability, MLTO's ROE is N/A, compared to MEPDF's ROE of +0.07%. Regarding short-term risk, MLTO is more volatile compared to MEPDF. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check MEPDF's competition here
MLTO vs MAHLY Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, MAHLY has a market cap of 3.6B. Regarding current trading prices, MLTO is priced at $0.00, while MAHLY trades at $17.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas MAHLY's P/E ratio is 14.37. In terms of profitability, MLTO's ROE is N/A, compared to MAHLY's ROE of +0.07%. Regarding short-term risk, MLTO is more volatile compared to MAHLY. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check MAHLY's competition here
MLTO vs ALFRY Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, ALFRY has a market cap of 2.9B. Regarding current trading prices, MLTO is priced at $0.00, while ALFRY trades at $16.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas ALFRY's P/E ratio is 19.09. In terms of profitability, MLTO's ROE is N/A, compared to ALFRY's ROE of +0.07%. Regarding short-term risk, MLTO is more volatile compared to ALFRY. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check ALFRY's competition here
MLTO vs AMFPF Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, AMFPF has a market cap of 2.2B. Regarding current trading prices, MLTO is priced at $0.00, while AMFPF trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas AMFPF's P/E ratio is 21.46. In terms of profitability, MLTO's ROE is N/A, compared to AMFPF's ROE of +0.09%. Regarding short-term risk, MLTO is more volatile compared to AMFPF. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check AMFPF's competition here
MLTO vs ARHCF Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, ARHCF has a market cap of 2.2B. Regarding current trading prices, MLTO is priced at $0.00, while ARHCF trades at $11.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas ARHCF's P/E ratio is 9.97. In terms of profitability, MLTO's ROE is N/A, compared to ARHCF's ROE of +0.07%. Regarding short-term risk, MLTO is more volatile compared to ARHCF. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check ARHCF's competition here
MLTO vs SZUKF Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, SZUKF has a market cap of 1.7B. Regarding current trading prices, MLTO is priced at $0.00, while SZUKF trades at $30.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas SZUKF's P/E ratio is 11.43. In terms of profitability, MLTO's ROE is N/A, compared to SZUKF's ROE of +0.09%. Regarding short-term risk, MLTO is more volatile compared to SZUKF. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check SZUKF's competition here
MLTO vs MEDOF Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, MEDOF has a market cap of 1.2B. Regarding current trading prices, MLTO is priced at $0.00, while MEDOF trades at $50.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas MEDOF's P/E ratio is 73.53. In terms of profitability, MLTO's ROE is N/A, compared to MEDOF's ROE of +0.04%. Regarding short-term risk, MLTO is more volatile compared to MEDOF. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check MEDOF's competition here
MLTO vs IUSDF Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, IUSDF has a market cap of 997.7M. Regarding current trading prices, MLTO is priced at $0.00, while IUSDF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas IUSDF's P/E ratio is 18.42. In terms of profitability, MLTO's ROE is N/A, compared to IUSDF's ROE of +0.13%. Regarding short-term risk, MLTO is more volatile compared to IUSDF. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check IUSDF's competition here
MLTO vs ARRJF Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, ARRJF has a market cap of 807.6M. Regarding current trading prices, MLTO is priced at $0.00, while ARRJF trades at $2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas ARRJF's P/E ratio is 22.81. In terms of profitability, MLTO's ROE is N/A, compared to ARRJF's ROE of +0.04%. Regarding short-term risk, MLTO is more volatile compared to ARRJF. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check ARRJF's competition here
MLTO vs EXHI Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, EXHI has a market cap of 16M. Regarding current trading prices, MLTO is priced at $0.00, while EXHI trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas EXHI's P/E ratio is N/A. In terms of profitability, MLTO's ROE is N/A, compared to EXHI's ROE of +0.00%. Regarding short-term risk, MLTO is more volatile compared to EXHI. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check EXHI's competition here
MLTO vs PDRX Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, PDRX has a market cap of 5.7M. Regarding current trading prices, MLTO is priced at $0.00, while PDRX trades at $3.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas PDRX's P/E ratio is 3.08. In terms of profitability, MLTO's ROE is N/A, compared to PDRX's ROE of -0.02%. Regarding short-term risk, MLTO is more volatile compared to PDRX. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check PDRX's competition here
MLTO vs NSVGF Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, NSVGF has a market cap of 3.3M. Regarding current trading prices, MLTO is priced at $0.00, while NSVGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas NSVGF's P/E ratio is -1.00. In terms of profitability, MLTO's ROE is N/A, compared to NSVGF's ROE of +0.21%. Regarding short-term risk, MLTO is more volatile compared to NSVGF. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check NSVGF's competition here
MLTO vs KOSK Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, KOSK has a market cap of 2.4M. Regarding current trading prices, MLTO is priced at $0.00, while KOSK trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas KOSK's P/E ratio is -0.19. In terms of profitability, MLTO's ROE is N/A, compared to KOSK's ROE of -0.14%. Regarding short-term risk, MLTO is more volatile compared to KOSK. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check KOSK's competition here
MLTO vs ITNS Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, ITNS has a market cap of 761.7K. Regarding current trading prices, MLTO is priced at $0.00, while ITNS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas ITNS's P/E ratio is -0.05. In terms of profitability, MLTO's ROE is N/A, compared to ITNS's ROE of +0.01%. Regarding short-term risk, MLTO is more volatile compared to ITNS. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check ITNS's competition here
MLTO vs ENMI Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, ENMI has a market cap of 383.1K. Regarding current trading prices, MLTO is priced at $0.00, while ENMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas ENMI's P/E ratio is -0.01. In terms of profitability, MLTO's ROE is N/A, compared to ENMI's ROE of +0.17%. Regarding short-term risk, MLTO is more volatile compared to ENMI. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check ENMI's competition here
MLTO vs CHME Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, CHME has a market cap of 239.5K. Regarding current trading prices, MLTO is priced at $0.00, while CHME trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas CHME's P/E ratio is -1.01. In terms of profitability, MLTO's ROE is N/A, compared to CHME's ROE of +0.04%. Regarding short-term risk, MLTO is more volatile compared to CHME. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check CHME's competition here
MLTO vs PHRX Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, PHRX has a market cap of 5.2K. Regarding current trading prices, MLTO is priced at $0.00, while PHRX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas PHRX's P/E ratio is N/A. In terms of profitability, MLTO's ROE is N/A, compared to PHRX's ROE of +0.85%. Regarding short-term risk, MLTO is more volatile compared to PHRX. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check PHRX's competition here
MLTO vs TGVN Comparison April 2026
MLTO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLTO stands at 1.7K. In comparison, TGVN has a market cap of 120. Regarding current trading prices, MLTO is priced at $0.00, while TGVN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLTO currently has a P/E ratio of -0.00, whereas TGVN's P/E ratio is -0.00. In terms of profitability, MLTO's ROE is N/A, compared to TGVN's ROE of N/A. Regarding short-term risk, MLTO is more volatile compared to TGVN. This indicates potentially higher risk in terms of short-term price fluctuations for MLTO.Check TGVN's competition here